STOCK TITAN

Schedule 13G: AQR Holdings LLC Discloses 6.68% Stake in XRAY

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

AQR Capital Management and its parent AQR Capital Management Holdings report a material passive stake in DENTSPLY SIRONA Inc. Together they beneficially own 13,316,771 shares of common stock, equal to 6.68% of the class. The filing shows shared voting and shared dispositive power over those shares and records no sole voting or dispositive power.

The Schedule 13G states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing lists the issuer headquarters in Charlotte, NC, gives AQR's Greenwich, CT address, and is signed by an authorized signatory on 08/14/2025. An exhibit notes AQR Capital Management, LLC is wholly owned by AQR Capital Management Holdings, LLC.

Positive

  • Material ownership disclosed: AQR reports 13,316,771 shares, representing 6.68% of DENTSPLY SIRONA's common stock, meeting SEC disclosure thresholds.
  • Clear governance posture: Filing certifies holdings were acquired and are held in the ordinary course and not to influence control, and uses Schedule 13G consistent with passive intent.
  • Organizational clarity: Exhibit states AQR Capital Management, LLC is wholly owned by AQR Capital Management Holdings, LLC, clarifying reporting relationship.

Negative

  • None.

Insights

TL;DR: AQR reports a >5% passive holding (13.3M shares, 6.68%) with shared voting and dispositive power; filing signals disclosure, not activism.

The Schedule 13G shows AQR and its parent hold 13,316,771 shares (6.68%), reported as shared voting and dispositive power and certified as held in the ordinary course of business. For investors, this is a material ownership disclosure because it exceeds the 5% threshold and must be monitored for changes, but the explicit certification and use of Schedule 13G indicate a passive intent rather than an active effort to influence management or control.

TL;DR: Material passive ownership disclosed; governance impact appears limited given shared power and the filer’s ordinary-course certification.

AQR's joint filing and the exhibit clarifying the subsidiary/parent relationship provide clear ownership lineage. Shared voting/dispositive power means AQR can influence votes if coordinated with others, but the certification under Item 10 and choice of Schedule 13G (rather than 13D) signal no current intent to pursue control. Stake size is material and should be tracked for any switch to active engagement or a 13D amendment.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



AQR Capital Management, LLC
Signature:Henry Parkin
Name/Title:Authorized Signatory
Date:08/14/2025
AQR Capital Management Holdings, LLC
Signature:Henry Parkin
Name/Title:Authorized Signatory
Date:08/14/2025
Exhibit Information

AQR Capital Management Holdings, LLC and AQR Capital Management, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.

FAQ

How many DENTSPLY SIRONA (XRAY) shares does AQR report owning?

AQR reports beneficial ownership of 13,316,771 shares, representing 6.68% of the class.

Who filed the Schedule 13G for XRAY?

The filing was made by AQR Capital Management, LLC and AQR Capital Management Holdings, LLC.

Does the filing indicate whether AQR has sole voting or dispositive power?

The filing shows 0 sole voting power and 0 sole dispositive power, with 13,316,771 shares recorded as shared voting and shared dispositive power.

When was the Schedule 13G signed?

The filing is signed by an authorized signatory on 08/14/2025.

Does the Schedule 13G state AQR intends to influence control of XRAY?

No. Item 10 certifies the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Where are DENTSPLY SIRONA's principal executive offices listed in the filing?

The filing lists the issuer's principal executive offices at 13320 Ballantyne Corporate Place, Charlotte, North Carolina.